Atea plunges after COVID-19 treatment fails to help patients in study

Go back to Atea plunges after COVID-19 treatment fails to help patients in study
(NASDAQ: AVIR) Delayed: 5.33 +0.07 (1.33%)
Previous Close $5.26    52 Week High $2.00 
Open $5.21    52 Week Low $1.15 
Day High $5.37    P/E N/A 
Day Low $5.17    EPS $0.00 
Volume 600,438